National Stockpiles Affect Medicine Access in Some EU Countries
Medicines for Europe shared on LinkedIn:
”Fragmented national stockpiling policies are making essential medicines harder to access in some EU countries, extending shortages and exposing our internal market.
In Germany, a 6-month stockpile equals almost 2 years’ supply for the Netherlands. Uncoordinated stockpiling risks destabilizing smaller markets and reducing treatment availability in other regions.
For example, 70% of companies have observed longer stockout periods and reduced availability of medicines in smaller markets, due to stockpiling requirements.
We need a unified approach to ensure timely and equal access for patients, as well as robust supply chains based on proportionate measures and EU solidarity.
Check out our report to learn more.”
Find more posts on Hemostasis Today.
-
Sep 25, 2026, 06:20Farjah Hassan Algahtani: How Can We Better Identify Patients at Risk of Blood Clots after Metabolic and Bariatric Surgery?
-
Sep 25, 2026, 05:59Carla Lewis: Kids Conquering Sickle Disease Joins Nemours Children’s Hospital for 2nd Annual Awareness Event
-
Sep 25, 2026, 05:47Omid Seidizadeh: Evolutionary Constraint and Population Variation Across Coagulation Genes
-
Sep 25, 2026, 05:40Gerald Bertrand: Presenting UMi-NGS Non-Invasive Foetal HPA Genotyping at DGTI 2026
-
Sep 25, 2026, 05:33Urge Congress to support the Sickle Cell Disease Comprehensive Care Act – ASH
-
Sep 25, 2026, 05:24Isabelle Mahé: Reduced-Dose Apixaban in Extended CAT Treatment
-
Sep 25, 2026, 05:15Maria Cherska: High Cholesterol Isn’t Always Diet or Lifestyle – Sometimes It’s Genetic
-
Sep 25, 2026, 05:07Nancy Braithwaite: BBTS Specialist Certificate in Transfusion Science Practice
-
Sep 24, 2026, 18:43Hugh Nguyen: Honored to Accept the Friend of Singapore Red Cross Award